11 May 2021 Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski Member news
11 May 2021 Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance Member news
14 Apr 2021 The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million Member news
31 Mar 2021 Confo Therapeutics awarded EUR 1M VLAIO grant for pre-clinical development of CFTX-1554 Member news
23 Mar 2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Member news
02 Mar 2021 Rejuvenate Biomed secures EUR 3.2 million series A round to advance development of healthy aging products Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
